Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in Trp53+/- mice
Main Authors: | Blackburn AC, Rooke M, Li Y, Dahlstrom JE, Board PG |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-04-01
|
Series: | Hereditary Cancer in Clinical Practice |
Online Access: | http://www.hccpjournal.com/content/10/S2/A62 |
Similar Items
-
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
by: Sun Ramon C, et al.
Published: (2011-11-01) -
Chemoprevention of Gastric Cancer: Metformin
by: Young-Il Kim, et al.
Published: (2017-12-01) -
Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
by: Tae Suk Kim, et al.
Published: (2021-09-01) -
Dichloroacetate reverses sepsis-induced hepatic metabolic dysfunction
by: Rabina Mainali, et al.
Published: (2021-02-01) -
Haploinsufficiency of Trp53 dramatically extends the lifespan of Sirt6-deficient mice
by: Shrestha Ghosh, et al.
Published: (2018-02-01)